FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

OncoCalendar

Loading Events

« All Events

  • This event has passed.

12th Annual Licensed Best of ASCO Meeting

Aug 23 - Aug 24
Best of ASCO

The 12th Annual Best of ASCO meeting hosted by AdventHealth Cancer Institute will take place on August 23-24, 2025, at The Ritz-Carlton Orlando, Grande Lakes, Florida. This event showcases top-rated scientific abstracts from the ASCO 2025 Annual Meeting, covering advances in cancer treatment, diagnostics, and evidence-based care.

It is designed for a wide range of oncology and related healthcare professionals. Participants can earn AMA PRA Category 1 Credit(s)TM, with nursing credits pending approval. The meeting focuses on applying ASCO data to clinical practice and improving patient care through the latest research and guidelines. Accessibility accommodations are available upon request.

Registration is open.

Venue

The Ritz-Carlton Orlando,
4012 Central Florida + Google Map